The gastrointestinal diseases drugs
market covers medicines used for the treatment of ulcerative colitis,
diverticular disease, perianal infections, anal fissures, hemorrhoids,
constipation, and irritable bowel syndrome. The key gastrointestinal diseases
drug categories include Anti-peptic agents (antacids, antagonists, Proton Pump
Inhibitors, Sucralfate, and Misoprostol), antiemetics, adsorbents,
anticholinergics, opiates, intestinal flora modifiers, emollient/surfactants,
hyperosmotic, saline, and simulant/irritant. The market numbers within this
briefing are restricted to pharmaceutical (drug) treatments and do not cover
biologic treatments for these conditions which are included in a separate
briefing.
Order
report at:
The global gastrointestinal drugs
market has been growing in the past years with a CAGR of almost 3%. The year
2017 recorded high growth in this market with a net market value more than 9%
higher than that of 2013, as per TBRC’s in-house consultants.
TBRC’s latest report show the historic
and future trends in the market for each year with sourced reasons to support
the growth claims.
The report also shows the global
gastrointestinal drugs market to grow at a higher CAGR by 2021 as compared to
2017, along with geographies best suited for investments with highest return
rate.
Download
sample report at:
Growing R&D activities for the
development of new drugs in the treatment of gastrointestinal diseases is an
emerging trend in the market. Some of the major gastrointestinal pipeline
products include Perjeta (Roche), Keytruda (Merck), TAS-118 (Taiho
Pharmaceutical), NeuVax (Galena Biopharma), Ipatasertib (Genentech), Durvalumab
(AstraZeneca) and Napabucasin (Boston Biomedical). Technological advances in
the treatment of gastrointestinal diseases are expected to boost the market
during the forecast period.
Companies included in the report are Takeda
Pharmaceuticals, Allergan Plc., and Novo Nordisk A/S.
About
The Business Research Company:
The Business Research Company is a
Business Intelligence Company which excels in company, market and consumer
research. It has offices in the UK, the US and India and a network of trained
researchers in 15 countries globally.
Contact
Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn:
https://in.linkedin.com/company/the-business-research-company
No comments:
Post a Comment